Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2022 Financial Results

Go back to Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2022 Financial Results
(NASDAQ: CRVS) Delayed: 13.44 +1.02 (8.21%)
Previous Close $12.42    52 Week High $17.77 
Open $12.55    52 Week Low $9.63 
Day High $13.46    P/E N/A 
Day Low $12.35    EPS $0.00 
Volume 806,628